In addition to healthcare and health economics aspects, new knowledge concerning the benefits and harms of various cervical cancer screening methods makes a reassessment of cervical cancer screening appear desirable.

  • Until now, opportunistic screening that is primarily based on cytology exists in Switzerland.
  • Opportunistic screening causes healthcare and health economics issues. On one hand, availability for certain vulnerable population groups is not guaranteed. On the other hand, there is a risk of oversupply for other population groups.
  • There are new test methods for high-risk types of human papillomavirus (hrHPV) that are proposed for cervical cancer screening – which could be used instead of the “Pap smear” cytology assessment.
  • In 2018, the USPSTF examined evidence in order to compare the benefits and harms of various cancer screening procedures – and then issued recommendations.
  • In March 2018, the Swiss Society for Gynecology and Obstetrics (SGGG) issued new recommendations on cervical cancer screening.